MedKoo Biosciences, Inc.
Tel:   +1-919-636-5577    Fax:   +1-919-980-4831    Email:   sales@medkoo.com
Search
Login Register
Search
MedKoo Cat#: 563529 | Name: Brilliant Blue G
Featured

Description:

WARNING: This product is for research use only, not for human or veterinary use.

Brilliant Blue G is a P2X7 purinergic receptor antagonist.

Chemical Structure

Brilliant Blue G
Brilliant Blue G
CAS#6104-58-1

Theoretical Analysis

MedKoo Cat#: 563529

Name: Brilliant Blue G

CAS#: 6104-58-1

Chemical Formula: C47H48N3NaO7S2

Exact Mass: 853.2831

Molecular Weight: 854.02

Elemental Analysis: C, 66.10; H, 5.67; N, 4.92; Na, 2.69; O, 13.11; S, 7.51

Price and Availability

Size Price Availability Quantity
5g USD 250.00 2 Weeks
25g USD 450.00 2 Weeks
Bulk Inquiry
Buy Now
Add to Cart
Related CAS #
No Data
Synonym
Brilliant Blue G; BBG; Acid blue 90; Coomassie Brilliant Blue G; NSC 328382; Coomassie Brilliant Blue G-250; CBBG;
IUPAC/Chemical Name
Sodium 3-[[4-[(E)-[4-(4-ethoxyanilino)phenyl]-[4-[ethyl-[(3-sulfonatophenyl)methyl]azaniumylidene]-2-methylcyclohexa-2,5-dien-1-ylidene]methyl]-N-ethyl-3-methylanilino]methyl]benzenesulfonate
InChi Key
RWVGQQGBQSJDQV-UHFFFAOYSA-M
InChi Code
InChI=1S/C47H49N3O7S2.Na/c1-6-49(31-35-11-9-13-43(29-35)58(51,52)53)40-21-25-45(33(4)27-40)47(37-15-17-38(18-16-37)48-39-19-23-42(24-20-39)57-8-3)46-26-22-41(28-34(46)5)50(7-2)32-36-12-10-14-44(30-36)59(54,55)56;/h9-30H,6-8,31-32H2,1-5H3,(H2,51,52,53,54,55,56);/q;+1/p-1
SMILES Code
O=S(C1=CC=CC(CN(CC)C2=CC=C(/C(C3=CC=C(NC4=CC=C(OCC)C=C4)C=C3)=C5C(C)=C/C(C=C/5)=[N+](CC)\CC6=CC=CC(S(=O)([O-])=O)=C6)C(C)=C2)=C1)([O-])=O.[Na+]
Appearance
Solid powder
Purity
>90% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>3 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.03.00
More Info

Preparing Stock Solutions

The following data is based on the product molecular weight 854.02 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
1: Ferreira LG, Faria RX, Ferreira NC, Soares-Bezerra RJ. Brilliant Blue Dyes in Daily Food: How Could Purinergic System Be Affected? Int J Food Sci. 2016;2016:7548498. Epub 2016 Oct 19. Review. PubMed PMID: 27833914; PubMed Central PMCID: PMC5090090. 2: Azuma K, Noda Y, Hirasawa K, Ueta T. BRILLIANT BLUE G-ASSISTED INTERNAL LIMITING MEMBRANE PEELING FOR MACULAR HOLE: A Systematic Review of Literature and Meta-Analysis. Retina. 2016 May;36(5):851-8. doi: 10.1097/IAE.0000000000000968. Review. PubMed PMID: 27115851. 3: Fumagalli M, Lecca D, Abbracchio MP. CNS remyelination as a novel reparative approach to neurodegenerative diseases: The roles of purinergic signaling and the P2Y-like receptor GPR17. Neuropharmacology. 2016 May;104:82-93. doi: 10.1016/j.neuropharm.2015.10.005. Epub 2015 Oct 8. Review. PubMed PMID: 26453964. 4: Burnstock G. An introduction to the roles of purinergic signalling in neurodegeneration, neuroprotection and neuroregeneration. Neuropharmacology. 2016 May;104:4-17. doi: 10.1016/j.neuropharm.2015.05.031. Epub 2015 Jun 6. Review. PubMed PMID: 26056033. 5: Goldring JP. Spectrophotometric methods to determine protein concentration. Methods Mol Biol. 2015;1312:41-7. doi: 10.1007/978-1-4939-2694-7_7. Review. PubMed PMID: 26043988. 6: Hernández F, Alpizar-Alvarez N, Wu L. Chromovitrectomy: an update. J Ophthalmic Vis Res. 2014 Apr;9(2):251-9. Review. PubMed PMID: 25279128; PubMed Central PMCID: PMC4181209. 7: Enaida H, Hisatomi T, Nakao S, Ikeda Y, Yoshida S, Ishibashi T. Chromovitrectomy and vital dyes. Dev Ophthalmol. 2014;54:120-5. doi: 10.1159/000360457. Epub 2014 Aug 26. Review. PubMed PMID: 25196760. 8: Panfoli I, Calzia D, Santucci L, Ravera S, Bruschi M, Candiano G. A blue dive: from 'blue fingers' to 'blue silver'. A comparative overview of staining methods for in-gel proteomics. Expert Rev Proteomics. 2012 Dec;9(6):627-34. doi: 10.1586/epr.12.63. Review. PubMed PMID: 23256673. 9: McElhiney LF. I see colors: using vital dyes in diagnosing ophthalmic disease. Int J Pharm Compd. 2012 May-Jun;16(3):190-5. Review. PubMed PMID: 23050295. 10: Han S, Auger C, Castonguay Z, Appanna VP, Thomas SC, Appanna VD. The unravelling of metabolic dysfunctions linked to metal-associated diseases by blue native polyacrylamide gel electrophoresis. Anal Bioanal Chem. 2013 Feb;405(6):1821-31. doi: 10.1007/s00216-012-6413-9. Epub 2012 Sep 22. Review. PubMed PMID: 23001308. 11: Ishibashi T. [Comprehensive strategy for retinal neuroprotection. Challenging the clinical application]. Nippon Ganka Gakkai Zasshi. 2012 Mar;116(3):165-98; discussion 199. Review. Japanese. PubMed PMID: 22568101. 12: de Campos NE, Marques-da-Silva C, Corrêa G, Castelo-Branco MT, de Souza HS, Coutinho-Silva R. Characterizing the presence and sensitivity of the P2X7 receptor in different compartments of the gut. J Innate Immun. 2012;4(5-6):529-41. doi: 10.1159/000336628. Epub 2012 Apr 13. Review. PubMed PMID: 22508425. 13: Takenouchi T, Sekiyama K, Sekigawa A, Fujita M, Waragai M, Sugama S, Iwamaru Y, Kitani H, Hashimoto M. P2X7 receptor signaling pathway as a therapeutic target for neurodegenerative diseases. Arch Immunol Ther Exp (Warsz). 2010 Apr;58(2):91-6. doi: 10.1007/s00005-010-0069-y. Epub 2010 Feb 9. Review. PubMed PMID: 20143170. 14: Friedle SA, Curet MA, Watters JJ. Recent patents on novel P2X(7) receptor antagonists and their potential for reducing central nervous system inflammation. Recent Pat CNS Drug Discov. 2010 Jan;5(1):35-45. Review. PubMed PMID: 19705995; PubMed Central PMCID: PMC2794961. 15: Kurien BT, Scofield RH. A brief review of other notable protein blotting methods. Methods Mol Biol. 2009;536:367-84. doi: 10.1007/978-1-59745-542-8_38. Review. PubMed PMID: 19378075. 16: Lebiedzińska M, Duszyński J, Wieckowski MR. [Application of "blue native" electrophoresis in the studies of mitochondrial respiratory chain complexes in physiology and pathology]. Postepy Biochem. 2008;54(2):217-23. Review. Polish. PubMed PMID: 18807933. 17: Enaida H, Ishibashi T. Brilliant blue in vitreoretinal surgery. Dev Ophthalmol. 2008;42:115-25. doi: 10.1159/000138989. Review. PubMed PMID: 18535385. 18: Reisinger V, Eichacker LA. Isolation of membrane protein complexes by blue native electrophoresis. Methods Mol Biol. 2008;424:423-31. doi: 10.1007/978-1-60327-064-9_33. Review. PubMed PMID: 18369880. 19: Simonian MH, Smith JA. Spectrophotometric and colorimetric determination of protein concentration. Curr Protoc Mol Biol. 2006 Nov;Chapter 10:Unit 10.1A. doi: 10.1002/0471142727.mb1001as76. Review. PubMed PMID: 18265371. 20: Gunosewoyo H, Coster MJ, Kassiou M. Molecular probes for P2X7 receptor studies. Curr Med Chem. 2007;14(14):1505-23. Review. PubMed PMID: 17584060.